IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MARVASO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.929
AS - Asia 8.420
NA - Nord America 7.952
SA - Sud America 913
AF - Africa 209
OC - Oceania 66
Continente sconosciuto - Info sul continente non disponibili 3
Totale 28.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.644
DE - Germania 5.478
SG - Singapore 2.435
CN - Cina 2.256
IT - Italia 2.180
BD - Bangladesh 1.001
HK - Hong Kong 933
BR - Brasile 701
VN - Vietnam 673
GB - Regno Unito 637
RU - Federazione Russa 595
SE - Svezia 531
FR - Francia 399
IN - India 350
NL - Olanda 242
IE - Irlanda 237
CA - Canada 199
FI - Finlandia 176
JP - Giappone 136
ID - Indonesia 133
CI - Costa d'Avorio 88
PH - Filippine 83
KR - Corea 80
AR - Argentina 76
DK - Danimarca 75
TR - Turchia 74
ES - Italia 69
AU - Australia 60
PL - Polonia 57
AT - Austria 47
BE - Belgio 42
EC - Ecuador 42
IQ - Iraq 39
ZA - Sudafrica 38
CH - Svizzera 33
MX - Messico 32
PK - Pakistan 30
UA - Ucraina 30
CL - Cile 26
MA - Marocco 21
IR - Iran 20
MY - Malesia 19
TH - Thailandia 19
TW - Taiwan 17
KE - Kenya 16
PE - Perù 16
CO - Colombia 15
AE - Emirati Arabi Uniti 13
HN - Honduras 13
SA - Arabia Saudita 13
VE - Venezuela 13
EG - Egitto 12
RO - Romania 12
JM - Giamaica 11
CZ - Repubblica Ceca 10
JO - Giordania 10
NO - Norvegia 10
PT - Portogallo 10
UZ - Uzbekistan 10
AL - Albania 9
CR - Costa Rica 9
KG - Kirghizistan 9
KZ - Kazakistan 9
OM - Oman 9
PY - Paraguay 9
TN - Tunisia 9
UY - Uruguay 9
AZ - Azerbaigian 8
GT - Guatemala 8
LT - Lituania 8
NG - Nigeria 8
TT - Trinidad e Tobago 8
DO - Repubblica Dominicana 7
GR - Grecia 7
NZ - Nuova Zelanda 6
BO - Bolivia 5
BY - Bielorussia 5
HU - Ungheria 5
LB - Libano 5
NP - Nepal 5
SV - El Salvador 5
DZ - Algeria 4
LU - Lussemburgo 4
RS - Serbia 4
SY - Repubblica araba siriana 4
AO - Angola 3
BG - Bulgaria 3
CU - Cuba 3
GE - Georgia 3
IL - Israele 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
PA - Panama 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
IS - Islanda 2
Totale 28.454
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 5.092
Singapore 1.295
Ashburn 1.137
Hong Kong 806
Dallas 653
San Jose 649
Milan 574
Chandler 522
Southend 428
Beijing 367
Hefei 314
Santa Clara 314
Los Angeles 308
Council Bluffs 282
New York 276
Dublin 233
Ho Chi Minh City 200
Princeton 198
Rome 186
Hanoi 169
Buffalo 168
Fairfield 163
Wilmington 154
Lauterbourg 140
Bengaluru 139
Helsinki 124
Phoenix 121
Moscow 112
Houston 103
Jakarta 99
Seattle 90
Abidjan 88
Boardman 86
Cambridge 85
Tokyo 85
Shanghai 80
Guangzhou 79
São Paulo 72
Munich 69
Toronto 68
Woodbridge 68
Naples 64
Ann Arbor 61
Columbus 61
Chicago 60
Des Moines 60
Seoul 52
Istanbul 51
Hyderabad 50
Turin 50
Cangzhou 49
Florence 48
Dearborn 46
London 46
Berlin 42
Nanjing 39
Nuremberg 38
Brussels 34
Atlanta 33
Jinan 33
Medford 31
Redwood City 31
Shenyang 31
Da Nang 30
Haiphong 30
Tianjin 30
Washington 30
Bari 29
Montreal 29
Amsterdam 28
Orem 28
Shenzhen 28
Warsaw 28
Bologna 27
Lappeenranta 26
Düsseldorf 25
Catania 24
Grafing 24
Rio de Janeiro 24
Sydney 24
The Dalles 24
Barcelona 23
Mumbai 23
Boston 22
Denver 22
Brescia 20
Brooklyn 20
Chennai 20
Genoa 20
Stockholm 20
Hải Dương 19
San Diego 19
Johannesburg 18
Turku 18
Hangzhou 17
Mannheim 17
Quanzhou 17
Central District 16
Changsha 16
Silver Spring 16
Totale 18.057
Salva come PNG Salva come JPEG
Nome #
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 481
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma 442
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 420
Whole-body magnetic resonance imaging: Technique, guidelines and key applications 402
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 371
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 356
STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia) : rationale and design of an Italian experimental prospective study 328
Automatic Segmentation with Deep Learning in Radiotherapy 326
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy 326
Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: A cross-sectional whole-body mri study 316
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 307
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 306
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 300
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 300
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 297
High-performance prediction models for prostate cancer radiomics 296
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300) 293
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 288
Head and neck cancer radiotherapy amid COVID‐19 pandemic : Report from Milan, Italy 285
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation 265
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 264
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 257
COVID-19 outbreak and cancer radiotherapy disruption in Italy : Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 256
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 255
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 255
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 255
Impact of a dedicated radiologist as a member of the head and neck tumour board : a single-institution experience 254
Mixup (Sample Pairing) Can Improve the Performance of Deep Segmentation Networks 251
Recent advances in radiation oncology 248
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 245
Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current Literature 243
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 242
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 242
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 240
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 234
Quality assurance for automatically generated contours with additional deep learning 232
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 231
Mixed-beam approach for high-risk prostate cancer : Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300) 230
Virtual and Augmented Reality as a Novel Opportunity to Unleash the Power of Radiotherapy in the Digital Era: A Scoping Review 228
Machine Learning for Head and Neck Cancer: A Safe Bet?—A Clinically Oriented Systematic Review for the Radiation Oncologist 227
Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients 226
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial 223
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy 223
Prognostic significance of neutrophil‐to‐lymphocyte ratio in HPV status era for oropharyngeal cancer 222
Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place 222
COVID-19 and radiotherapy: impact on work and personal life of Lombardy residents during first lockdown, survey endorsed by AIRO Young 220
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 218
Influence of different urinary bladder filling levels and controlling regions of interest selection on deformable image registration algorithms 216
Almost one year of COVID-19 pandemic : how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 215
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 213
Biomedical omics : first insights of a new MSc degree of the University of Milan 213
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 212
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion : a plan comparison 207
Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey 205
The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases: A case report 203
Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer 201
The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors 201
Erratum: Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation (La Radiologia medica (2019) 124 1 (65-78)) 200
Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 199
Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach 198
IMRT versus 2D/3D conformal RT in oropharyngeal cancer: A review of the literature and meta-analysis 198
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis 194
Indication to postoperative radiotherapy for oral cavity squamous cell carcinoma: what's new in the Depth of Infiltration (DOI) era? 193
Recurrent oligometastatic transitional cell bladder carcinoma: is there room for radiotherapy? 192
COVID-19 manifestation in the oral cavity – A narrative literature review 191
COVID-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, Italy 191
Oligo metastatic renal cell carcinoma : stereotactic body radiation therapy, if, when and how? 189
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer : A Propensity Score Analysis 187
Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone 185
Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro 185
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists 185
More than Five Decades of Proton Therapy: A Bibliometric Overview of the Scientific Literature 181
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis 178
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models 178
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation : results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 178
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer 177
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates 175
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 175
A Phase 3 Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperativane Surgical Margins: A Clinical Trial Protocol 174
What is the best time for postoperative radiation therapy in pN1 prostate cancer? 172
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time 169
Case series on multiple prostate re-irradiation for locally recurrent prostate cancer: something ventured, something gained 168
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus 168
Systemic inlammatory status at baseline predicts bevacizumab beneit in advanced non-small cell lung cancer patients 165
Lung optimized treatment with cyberknife® in inoperable lung cancer patients: Feasibility analysis of a mono-institutional 115 patient series 165
Combination of novel systemic agents and radiotherapy for solid tumors - Part II : an AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 162
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer 159
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 159
Combination of novel systemic agents and radiotherapy for solid tumors - part I : An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 158
Methods of topical administration of drugs and biological active substances for dental implants — A narrative review 158
Re: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial 158
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion 157
Effects of MRI image normalization techniques in prostate cancer radiomics 154
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group 154
Nutritional Intervention for Nonsurgical Head and Neck Cancer Patients Treated with Radiation Therapy : Results from a Prospective Stepped-Wedge Clinical Protocol 152
Any role of pik3ca and pten biomarkers in the prognosis in oral squamous cell carcinoma? 152
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression 151
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 151
High pd-l1 expression on tumor cells indicates worse overall survival in advanced oral squamous cell carcinomas of the tongue and the floor of the mouth but not in other oral compartments 151
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia 149
Totale 22.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.400 49 54 54 44 101 87 60 106 113 198 108 426
2022/20232.146 243 237 200 171 150 376 75 160 270 28 177 59
2023/20244.820 66 94 140 82 340 191 764 658 352 623 778 732
2024/20255.417 729 712 626 551 272 177 148 343 228 385 467 779
2025/202613.142 1.258 1.065 1.354 1.114 895 594 1.637 470 1.092 743 1.641 1.279
2026/2027267 267 0 0 0 0 0 0 0 0 0 0 0
Totale 29.350